The New England Journal of Medicine
HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   HELP   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
* This Week in the Journal
 April 20, 2006
 Audio Icon Audio Summary
*
Correspondence
* Rotavirus Vaccines
* Intensive Diabetes Treatment and Cardiovascular Disease
* Inhaled Cyclosporine in Lung Transplantation
* Patent Foramen Ovale and Unexplained Stroke
* Aneurysmal Subarachnoid Hemorrhage
* Lead Shot in the Appendix
* Donor-Derived T-Cell Leukemia after Bone Marrow Transplantation
* A Case of Platydeoxia?
*
Book Reviews
* The Medical Malpractice Myth
How to Become a Dangerous Expert Witness: Advanced Techniques and Strategies
* Handbook of Families and Health: Interdisciplinary Perspectives
* Handbook of Urban Health: Populations, Methods, and Practice
Original Articles
Efficacy and Safety of Corticosteroids for Persistent ARDS

The use of systemic corticosteroids in the treatment of the acute respiratory distress syndrome (ARDS) is controversial. In this study, 180 patients were treated with methylprednisolone sodium succinate or placebo within 7 to 28 days after the onset of ARDS. There was no significant difference in mortality at 60 or 180 days; thus, treatment of ARDS with systemic corticosteroids is not recommended.

Related Editorial


Original Articles
A Therapeutic Intervention for Prehypertension

Persons with prehypertension (formerly, "borderline hypertension") were randomly assigned in a blinded fashion to receive two years of candesartan or placebo, followed by two years of placebo for all. Over four years, therapy with candesartan reduced the risk of the development of hypertension by 15.6 percent (P<0.007). Further research is needed to evaluate the clinical usefulness and ultimate safety of antihypertensive treatment for prehypertension.

Related Editorial


Original Articles
Oral Ondansetron for Gastroenteritis in a Pediatric Emergency Department

In this randomized, controlled trial in children who presented to an emergency department with vomiting and dehydration due to gastroenteritis, a single dose of oral ondansetron reduced vomiting, facilitated oral rehydration, and decreased the use of intravenous rehydration. The rate of hospitalization was low (4 percent) and was not significantly reduced by treatment with ondansetron.


Original Articles
Clopidogrel and Aspirin versus Aspirin Alone to Prevent Atherothrombotic Events

The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial compared clopidogrel plus aspirin with aspirin alone for reducing the rate of myocardial infarction, stroke, or death from cardiovascular causes in patients with stable cardiovascular disease or multiple cardiovascular risk factors. There was no difference between the treatment groups in this outcome.

Related Editorial

Related Perspective


Clinical Practice
Scabies

A 30-year-old man notes diffuse, intense itching. He reports that his girlfriend has the same itchiness. Examination of the skin reveals interdigital lesions, with small papules, vesicles, and excoriations on the hands and indurated nodules on the genitalia, all of which are suggestive of classic scabies. How should this case be managed?


Case Records of the Massachusetts General Hospital
A Man with Hemoptysis and a Pulmonary Infiltrate

A 37-year-old physician was seen in the pulmonary clinic because of night sweats, hemoptysis, and a mass-like infiltrate visible in the lower lobe of the right lung on computed tomography (CT). He was otherwise in good health; a recent tuberculin skin test was negative, and the results of a physical examination and routine laboratory tests were normal. Antibiotics were prescribed, and the infiltrate resolved, but night sweats continued. CT repeated three months later disclosed new lesions in the same lobe. A diagnostic procedure was performed.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.